- Home
- ORGO vs NREF Comparison
ORGO vs NREF Comparison
Compare ORGO & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORGO | NREF |
|---|---|---|
| Founded | 1985 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.8M | 296.5M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORGO | NREF |
|---|---|---|
| Price | $2.41 | $16.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | $8.50 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 744.0K | 58.9K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 13.95% |
| EPS Growth | ★ 1600.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $564,169,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $26.27 | $10.47 |
| P/E Ratio | ★ N/A | $4.78 |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $2.04 | $12.36 |
| 52 Week High | $7.08 | $17.22 |
Technical Indicators
Market Signals| Indicator | ORGO | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 61.83 |
| Support Level | $2.23 | $13.73 |
| Resistance Level | $2.62 | $17.22 |
| Average True Range (ATR) | 0.14 | 0.39 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 35.16 | 71.19 |
Price Performance
Historical ComparisonAbout ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a commercial mortgage REIT focused on generating attractive, risk-adjusted returns for shareholders over the long term. The company invests mainly in first-lien mortgage loans, mezzanine loans, preferred equity, multifamily properties, and common equity investments, as well as multifamily and single-family rental CMBS securitizations, promissory notes, revolving credit facilities, and stock warrants. It focuses on real estate sectors where its management has operating expertise, including multifamily, single-family rental, self-storage, industrial, and life sciences, mainly in top metropolitan areas.